Association of arterial stiffness, N-terminal pro-brain natriuretic peptide, insulin resistance, and left ventricular diastolic dysfunction with diabetic cardiac autonomic neuropathy

Abstract

Aim: To investigate the changes of insulin resistance (IR), parameters of arterial stiffness, concentrations of N-terminal pro-brain natriuretic peptide (NT-proBNP), and echocardiographic parameters in patients with cardiac autonomic neuropathy (CAN) and type 2 diabetes mellitus (T2D).

Methods: This study recruited 44 patients with T2D (19 patients without CAN and 25 patients with CAN) and 15 healthy volunteers. Arterial stiffness, immunoreactive insulin, homeostasis model assessment IR, NT-proBNP parameters, and echocardiographic examination were assessed.

Results: Development of CAN is associated with increase in NT-proBNP levels, IR parameters, and arterial stiffening. Among patients with CAN, arterial stiffness parameters were considered as high. We found out that among patients of this group, the value of brachial augmentation index was normal in 52%, elevated in 40%, and pathological in 8%; pulse wave velocity was normal in 16%, elevated in 52%, and pathological in 32% of cases. Obtained results showed that development of CAN is accompanied by more pronounced left ventricular diastolic dysfunction and by formation of left ventricular hypertrophy (LVH), mostly by concentric type. Among patients of this group concentric LVH was diagnosed among 76 % and eccentric LVH among 16% of persons. Multiple regression analysis, after controlling for age, sex, diabetes duration, blood pressure, HbA1c, and left ventricular mass index, showed an independent association of heart rate response to deep breathing with pulse wave velocity (P < 0.001).

Conclusion: Development of CAN is associated with increased IR parameters, increased levels of NT-proBNP, arterial stiffening, left ventricular diastolic dysfunction, and formation of LVH, mostly by concentric type.

Keywords

Arterial stiffness / cardiac autonomic neuropathy / echocardiography / insulin resistance / myocardium / N-terminal pro-brain natriuretic peptide / type 2 diabetes mellitus

References

[1] Jia G,Sowers JR.Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease.Diabetologia2018;61:21-8 PMCID:PMC5720913

[2] Va S,Aa S.Diabetic cardiac autonomic neuropathy and arterial stiffness-which comes first?.Diabetes Updates2018;1:1-5

[3] Shah MS.Molecular and cellular mechanisms of cardiovascular disorders in diabetes.Circ Res2016;118:1808-29 PMCID:PMC4888901

[4] Mala S,Hoskovcova L.Cardiac autonomic neuropathy may play a role in pathogenesis of atherosclerosis in type 1 diabetes mellitus.Diabetes Res Clin Pract2017;134:139-44

[5] Didangelos TP,Karamitsos T.Left ventricular systolic and diastolic function in normotensive type 2 diabetic patients with or without autonomic neuropathy: a radionuclide ventriculography study.Angiology2014;65:877-82

[6] Shang Y,Leng W.Increased fractal dimension of left ventricular trabeculations is associated with subclinical diastolic dysfunction in patients with type-2 diabetes mellitus.Int J Cardiovasc Imaging2019;35:665-73

[7] Flotats A.Is cardiac autonomic neuropathy the basis of nonischemic diabetic cardiomyopathy?.JACC Cardiovasc Imaging2010;3:1216-8

[8] Chorepsima S,Tentolouris T.Pulse wave velocity and cardiac autonomic function in type 2 diabetes mellitus.BMC Endocrine Disord2017;17:27 PMCID:PMC5438530

[9] de Oliveira Alvim R,Musso MM.Impact of diabetes mellitus on arterial stiffness in a representative sample of an urban Brazilian population.Diabetol Metab Syndr2013;5:45 PMCID:PMC3765236

[10] Chinnaiyan KM.Role of stress management for cardiovascular disease prevention.Curr Opin Cardiol2019;34:531-5

[11] Jia G,Sowers JR.Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.Nat Rev Endocrinol2016;12:144-53 PMCID:PMC4753054

[12] Negishi K.Echocardiographic feature of diabetic cardiomyopathy: where are we now?.Cardiovasc Diagn Ther2018;8:47-56 PMCID:PMC5835643

[13] Ponte CMM,Liberato CBR.Association between cardiovascular autonomic neuropathy and left ventricular hypertrophy in young patients with congenital generalized lipodystrophy.Diabetol Metab Syndr2019;11:53 PMCID:PMC6604128

[14] Krzesiński P,Gielerak G.Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.Adv Clin Exp Med2017;26:295-301

[15] Assembly of the World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.J Am Coll Dent2014;81:14-8

[16] Diabetes Association. 2. Classification and diagnosis of diabetes.Diabetes Care2017;40:S11-24

[17] Williams B,Spiering W.ESC Scientific Document Group2018 ESC/ESH Guidelines for the management of arterial hypertension.Eur Heart J2018;39:3021-104

[18] Spallone V,Freeman R.Toronto Consensus Panel on Diabetic NeuropathyCardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management.Diabetes Metab Res Rev2011;27:639-53

[19] Newman AB,Manolio TA.Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.Circulation1993;88:837-45

[20] Matthews DR,Rudenski AS,Treacher DF.Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.Diabetologia1985;28:412-9

[21] Horváth IG,Lenkey Z.Invasive validation of a new oscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity.J Hypertens2010;28:2068-75

[22] Townsend RR,Schiffrin EL.American Heart Association Council on HypertensionRecommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association.Hypertension2015;66:698-722 PMCID:PMC4587661

[23] Nagueh SF,Appleton CP.Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the american society of echocardiography and the European association of cardiovascular imaging.J Am Soc Echocardiogr2016;29:277-314

[24] Bamira D. Imaging: echocardiology-assessment of cardiac structure and function. In: Vasan RS, Sawyer DB, editors. Encyclopedia of cardiovascular structure and function. Amsterdam, Oxford, Cambridge: Elsevier; 2018. p. 35-54.

[25] Loncarevic B,Soldatovic I.Silent diabetic cardiomyopathy in everyday practice: a clinical and echocardiographic study.BMC Cardiovasc Disord2016;16:242 PMCID:PMC5126872

[26] Lang TA.How to report statistics in medicine: annotated guidelines for authors, editors, and reviewers. 2nd ed. Philadelphia: American College of Physicians; 2006. p. 45-74.

[27] Kozakova M.Diabetes mellitus, arterial wall, and cardiovascular risk assessment.Int J Environ Res Public Health2016;13:201 PMCID:PMC4772221

[28] Bagherzadeh A,Tajallizade-Khoob Y.Association of cardiac autonomic neuropathy with arterial stiffness in type 2 diabetes mellitus patients.J Diabetes Metab Disord2013;12:55 PMCID:PMC7983836

[29] Barazzoni R,Gortan Cappellari G.Fatty acids acutely enhance insulin-induced oxidative stress and cause insulin resistance by increasing mitochondrial reactive oxygen species (ROS) generation and nuclear factor-κB inhibitor (IκB)-nuclear factor-κB (NFκB) activation in rat muscle, in the absence of mitochondrial dysfunction.Diabetologia2012;55:773-82

[30] Seko Y.A novel and dominant factor that mediates oxidative stress-induced apoptotic signaling - autocrine/paracrine mechanism of the secreted form of eukaryotic translation initiation factor 5A.Vessel Plus2020;4:22

[31] Madamanchi NR,Runge MS.Oxidative stress and vascular disease.Arterioscler Thromb Vasc Biol2005;25:29-38

[32] Ulleryd MA,Börsbo J.The association between autonomic dysfunction, inflammation and atherosclerosis in men under investigation for carotid plaques.PLoS One2017;12:e0174974 PMCID:PMC5380339

[33] Çakar M,Şarlak H.Arterial stiffness and endothelial inflammation in prediabetes and newly diagnosed diabetes patients.Arch Endocrinol Metab2015;59:407-13

[34] Çiftel M,Parlak M,Kardelen F.Investigation of endothelial dysfunction and arterial stiffness in children with type 1 diabetes mellitus and the association with diastolic dysfunction.Diab Vasc Dis Res2014;11:19-25

[35] Zhao XY,Li L.Effects of high glucose on human umbilical vein endothelial cell permeability and myosin light chain phosphorylation.Diabetol Metab Syndr2015;7:98 PMCID:PMC4650340

[36] Lin H,Wu ZH,Chen XY.[Association of pro-B-type natriuretic peptide levels with heart rate variability in diabetic patients].Nan Fang Yi Ke Da Xue Xue Bao2015;35:146-8. (in Chinese)

[37] Bianchi L,Banu I,Cosson E.Influence of cardiac autonomic dysfunction and arterial stiffness on subendocardial myocardial viability in patients with type 2 diabetes.Diabetes Metab2016;42:297-8

[38] Valensi P,Harfouche B.Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia.Diabetes Care2001;24:339-43

[39] Sacre JW,Jellis CL,Coombes JS.Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes.JACC Cardiovasc Imaging2010;3:1207-15

[40] Yeboah K,Gyan B.Arterial stiffness in nonhypertensive type 2 diabetes patients in Ghana.Int J Endocrinol2016;2016:6107572 PMCID:PMC5059649

[41] Christen AI,Miranda A.Arterial wall structure and dynamics in type 2 diabetes mellitus methodological aspects and pathophysiological findings.Curr Diabetes Rev2010;6:367-77

[42] Stoner L,Fryer S.Assessments of arterial stiffness and endothelial function using pulse wave analysis.Int J Vasc Med2012;2012:903107 PMCID:PMC3361177

[43] Smulyan H,Safar ME.Hypertension, diabetes type II, and their association: role of arterial stiffness.Am J Hypertens2016;29:5-13